In human models of migraine, a suspected pharmacological migraine trigger is administered either orally or via infusion to a participant with migraine or a healthy volunteer, typically within a double-blind, randomized, placebo-controlled design.1 This allows for the identification of molecules involved in the generation of migraine attacks, and thereby reveals potential treatment targets. Moreover, migraine attacks can be reliably induced to investigate their pathophysiological underpinnings using e.g. advanced magnetic resonance imaging to investigate vasodilation or changes in neuronal activity.

MRI = Magnetic Resonance Imaging; PACAP-38 = Pituitary Adenylate Activating Polypeptide-38.

file_download Download in HQ

Related content

Human Models of Migraine and Scientific Advances play_circle Video play_circle
Human Models of Migraine and Scientific Advances

Discover how human models of migraine have identified key molecular triggers like CGRP and PACAP, revolutionizing treatment options and offering hope for patients unresponsive to current therapies.

16.12.2024 Migraine
description Article
Human Models of Migraine and Scientific Advances in Migraine Treatments

Migraine is a prevalent neurological disorder characterized by recurrent and disabling attacks of moderate to severe headache

21.11.2024 Migraine
image Image Prevalence of Migraine
Prevalence of Migraine

Migraine affects an estimated 1.1 billions worldwide and ranks as the 2nd leading cause of disability, while being the leading among young adults.

21.11.2024 Migraine